Sectors
As managing partner at JLL Spark, Singh will help manage the property technology investment fund.
11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.
Alphabet, AutoNation and Magna International all returned to reinvest in the driverless car technology developer having backed a $3.2bn round last year.
The payment card technology provider, which counts Visa, CommerzBank, CreditEase and Mastercard as investors, has added about $190m to close its IPO.
GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.
Motif FoodWorks, launched by Gingko Bioworks, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Gingko agreed to a reverse merger.
SoftBank Vision Fund 2 co-led a series B round for immunotherapy developer Umoja Biopharma with Cormorant Asset Management.
Propel Venture Partners has helped the retirement plan provider increase its overall funding to $344m by investing in a round led by General Atlantic.
The CreditEase-backed wealth management software provider was valued at $2bn after securing investment from D1 Capital Partners.
Shell Ventures has re-upped in G2 Venture Partners’ sophomore fund, which was also backed by Mitsui, Daimler and ABB Switzerland.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
